New Research: COVID-19 mRNA Vaccines May Improve Cancer Immunotherapy Outcomes

New research indicates that COVID-19 mRNA vaccines might improve outcomes in some patients receiving cancer immunotherapy. Here’s what this could mean — and how Woodstock Road Chemist can support you with vaccine guidance and convenient clinic bookings.

At a glance


References & further reading

  1. Grippin A. J. et al. “SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.” Nature. 2025. DOI: 10.1038/s41586-025-09655-y. Nature+2MD Anderson Cancer Center+2

  2. MD Anderson Cancer Center. “mRNA-based COVID-19 vaccines generate improved response in cancer immunotherapy” (Press Release). 2025. MD Anderson Cancer Center

  3. Chen A. “mRNA COVID shots may boost effects of cancer immunotherapy — lung cancer, melanoma.” STAT. 19 October 2025. STAT

  4. “Tumours might be sensitised to immune therapy by COVID mRNA vaccines.” Nature Synopsis. 2025. Nature

Suggested Link

Nature article


Medical disclaimer

This article is for general information only and is not a substitute for medical advice. Always speak to your oncologist, GP, or healthcare professional about your specific circumstances.